The report “Clinical Trial Supplies Market by products & Services (Logistics & Distribution, Manufacturing, Packaging and Labeling), Phases (Phase I, Phase II, Phase III) & Therapeutic Areas (CNS & Mental Disorders, Cardiovascular, Oncology) - Global Forecast to 2020” provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the clinical trial supplies market along with the estimates and forecasts of the revenue and market share analysis.

Browse 70 tables and 36 figures spread through 134 pages and in-depth TOC on "Clinical Trial Supplies Market by products & Services (Logistics & Distribution, Manufacturing, Packaging and Labeling), Phases (Phase I, Phase II, Phase III) & Therapeutic Areas (CNS & Mental Disorders, Cardiovascular, Oncology) - Global Forecast to 2020"
https://www.marketsandmarkets.com/Market-Reports/clinical-trial-supplies-market-172240059.html
Early buyers will receive 10% customization on reports.

The global clinical trial supplies market is expected to reach USD 1,274.3 Million by 2020 from USD 904.3 Million in 2015, at a CAGR of 7.1% from 2015 to 2020.

The report segments this market based on products and services, phases, therapeutic areas, and regions. Among the various products and services, the logistics and distribution services segment is expected to account for the largest share of the market and is projected to grow at the highest CAGR from 2015 to 2020. The high growth in this segment can be attributed to the factors such as globalization of clinical trials and increasing outsourcing of services.

On the basis of phases, the clinical trial supplies market is segmented into phase I, phase II, and phase III. The phase III segment is expected to account for the largest share of the global clinical trial supplies market in 2015. Large sample size of patients and high cost of phase III trials are the factors propelling the growth of this market.

Therapeutic areas, included in the clinical trial supplies market are oncology, cardiovascular diseases, respiratory diseases, CNS and mental disorders, dermatology disorders, blood disorders, infectious diseases, and others. The oncology segment is expected to account for the largest share of the global clinical trial supplies market in 2015. Increase in cancer incidences and government funding for cancer research are factors driving the growth of this market.

Based on regions, the global clinical trial supplies market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as rising prevalence of chronic diseases, growing number of clinical trials, and the increasing number of life sciences research activities in North America.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=172240059

Key players in the clinical trial supplies market include Alamc Group LTD (U.K.), Biocair (U.K.), Catalent Pharma Solutions, Inc. (U.S.), KLIFO A/S (Denmark), Movianto (Germany), PCI Services (U.S.), Patheon, Inc. (U.S.), PAREXEL International Corporation (U.S.), Sharp Packaging Services (U.S.), and Thermo Fisher Scientific, Inc. (U.S.)

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]